Clinical Trials Directory

Trials / Completed

CompletedNCT02440555

Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose

Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose Compared to Current Screening in the Priority Health Area of Saint-Etienne and the Sainté Diabète Network.

Status
Completed
Phase
Study type
Observational
Enrollment
1,305 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Accepted

Summary

Type 2 diabetes is the chronic disease with the most important development in France, and particularly in the Saint-Etienne area due to his specific population. Different studies showed the interest of screening targeted on high risk population to reduce cardiovascular risks and mortality. The current screening recommandation is an opportunist targeted screening on population older than 45 years with risk factors by a fasting glucose every 3 years, and a communautaire screening targeted on population older than 45 years suffering precarity with or without risk factors by capillary blood glucose or fasting glucose. The objective of the Sainté Diabete network is to optimize the screening of diabetics, their follow-up and their treatments. Using a self-administered questionnaire during a medical visit could be a simple, cheap and efficient tool to detect diabetics as soon as possible.

Conditions

Interventions

TypeNameDescription
OTHERfulfill the self-administered questionnairePatients viewed in a pharmacy or a hospital fulfill the self-administered questionnaire before having a capillary blood glucose measurement.

Timeline

Start date
2014-11-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2015-05-12
Last updated
2016-05-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02440555. Inclusion in this directory is not an endorsement.